Trial Profile

A pivotal Phase 3, randomized, double-Blinded, vehicle-controlled study of sofpironium bromide gel 5% targeting patients with primary axillary hyperhidrosis in Japan

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 14 Jun 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

01 Jun 2022 Results assessing 2-week efficacy and safety of 5% sofpironium bromide gel in Japanese patients with primary axillary hyperhidrosis, published in the Journal of Dermatology.
05 Mar 2021 According to a Brickell Biotech Inc media release, topline data from Phase 3 clinical program is expected in the fourth quarter of 2021.
19 Jan 2021 According to a Brickell Biotech Inc media release, data from this study were published in the peer-reviewed Journal of Dermatology.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com